J

Jafron Biomedical Co Ltd
SZSE:300529

Watchlist Manager
Jafron Biomedical Co Ltd
SZSE:300529
Watchlist
Price: 31.81 CNY 1.4% Market Closed
Market Cap: 25.7B CNY
Have any thoughts about
Jafron Biomedical Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

28.6
Current
26.2
Median
12.6
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
28.6
=
Enterprise Value
24.5B CNY
/
EBITDA
856.6m CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
17.2
2-Years Forward
EV/EBITDA
13.1
3-Years Forward
EV/EBITDA
10.7

See Also

Discover More